Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Dissection-independent production of Plasmodium sporozoites from whole mosquitoes.

Blight J. et al, (2021), Life science alliance, 4

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Barrett JR. et al, (2021), Nature Medicine, 27, 1113 - 1113

Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Ewer KJ. et al, (2021), Nature Medicine, 27, 1116 - 1116

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

Frater J. et al, (2021), The Lancet HIV

Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice.

Collins KA. et al, (2021), Scientific reports, 11

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.

Datoo MS. et al, (2021), Lancet (London, England), 397, 1809 - 1818

A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development.

Atcheson E. et al, (2021), NPJ vaccines, 6

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Emary KRW. et al, (2021), The Lancet, 397, 1351 - 1362

Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccination.

Müller K. et al, (2021), EMBO molecular medicine, 13

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies

Folegatti PM. et al, (2021), Vaccines, 9, 262 - 262

Mapping immune variation and var gene switching in naive hosts infected with Plasmodium falciparum

Milne K. et al, (2021), eLife, 10

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Voysey M. et al, (2021), The Lancet, 397, 881 - 891

COVID-19 Vaccines: Global Challenges and Prospects Forum Recommendations.

Boudjelal M. et al, (2021), Int J Infect Dis

Malaria is a cause of iron deficiency in African children.

Muriuki JM. et al, (2021), Nat Med

COVID-19 vaccines for rapid global impact.

Hill AVS., (2021), BJU Int, 127, 137 - 139

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Barrett JR. et al, (2021), Nature Medicine, 27, 279 - 288

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Ewer KJ. et al, (2021), Nature Medicine, 27, 270 - 278

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Voysey M. et al, (2021), The Lancet, 397, 99 - 111

Immunological considerations for SARS-CoV-2 human challenge studies

Douglas AD. and Hill AVS., (2020), Nature Reviews Immunology, 20, 715 - 716

Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule

Rollier CS. et al, (2020), Scientific Reports, 10

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?